Portfolio company
Levels Diagnostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops protein biomarker tests to help medical professionals diagnose infectious diseases and detect early-stage liver cancer from blood samples.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Aged Diagnostics
The company develops non-invasive blood tests to diagnose liver disease and stage fibrosis for healthcare providers and patients.
Cleveland Diagnostics
This company develops blood-based protein biomarker tests for early cancer detection to help clinicians and laboratories identify high-risk patients and reduce unnecessary biopsies.
Astute Medical
This company develops in vitro diagnostic tests for hospitals and laboratories to identify sepsis, infectious diseases and other medical conditions.
Hepta Bio
This company develops AI-powered blood tests for chronic liver disease diagnostics to assist clinicians and pharmaceutical companies with patient identification and monitoring.
Glycotest
This company develops non-invasive blood tests for the early detection of liver cancers and fibrosis-cirrhosis in patients with chronic liver disease.
Range Bio
This company develops protein quantification tools for researchers and clinicians to improve diagnostic medicine and accelerate drug development.
InterVenn BioSciences
This company develops glycoproteomic diagnostic tests and an AI-driven analysis platform for clinicians and biopharmaceutical partners to improve disease detection and treatment.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
